FDA Grants Orphan Drug Designation to GC Biopharma’s Drug Candidate for Thrombotic Thrombocytopenic Purpura
When designated as an orphan drug, there are incentives such as tax credits for clinical development costs and…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
09 Oct 23
When designated as an orphan drug, there are incentives such as tax credits for clinical development costs and…
06 Oct 23
The deal includes Mitokinin's lead asset, a selective PINK1 activator, which is designed to mitigate mitochondrial dysfunction factor…
06 Oct 23
The misplacement and loss of equipment and diagnostic samples, among other resources, results in hours of wasted time…
05 Oct 23
Risvodetinib is a chronically administered oral drug candidate that targets the underlying biological mechanism of Parkinson’s disease with…
05 Oct 23
AnemoCheck Home is the only FDA-cleared home anemia test with instant results
05 Oct 23
Featured presentations highlight how Seven Bridges delivers flexibility, compatibility and collaboration in support of key initiatives like AI/ML…
05 Oct 23
The program is designed to help patients access treatment, providing prescription fulfillment services, insurance benefits investigation, educational support,…
04 Oct 23
The United Nations’ health agency will consider the SAGE’s recommendation and revise its position paper on dengue vaccines…
04 Oct 23
The updated vaccine addresses currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization…
03 Oct 23
The drugmaker has received offer for its OTC business, and has agreed to divest its women's healthcare business,…